Stablecoin Development Corp S-8, filed Jan 22, 2010: NOVABAY S-8 1-21-2010
As filed
with the Securities and Exchange Commission on January 21, 2010
Registration
No. 333-
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
____________________
FORM
S-8
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
____________________
NovaBay
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
|
California
|
68-0454536
|
|
|
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
____________________
5980
Horton Street, Suite 550
Emeryville,
CA 94608
(510)
899-8800
____________________
2007
Omnibus Incentive Plan
(Full
title of the plan)
____________________
Ramin
(“Ron”) Najafi, Ph.D.
Chief
Executive Officer
5980
Horton Street, Suite 550
Emeryville,
CA 94608
(510)
899-8800
(Name,
address, including zip code, and telephone number, including area code, of agent
for service)
____________________
Copies
to:
Brett
D. White, Esq.
Cooley
Godward Kronish llp
Five
Palo Alto Square
3000
El Camino Real
Palo
Alto, CA 94306-2155
(650)
843-5000
_____________________
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
|
Large
accelerated filer □
|
|
Accelerated
filer □
|
|
Non-accelerated
filer □
|
|
Smaller
reporting company ⌧
|
|
(Do
not check if a smaller reporting company)
|
CALCULATION
OF REGISTRATION FEE
|
Title
of Securities to be Registered
|
Amount to be
registered(1)
|
Proposed maximum offering price
per share(2)
|
Proposed
maximum aggregate offering price
|
Amount
of
registration
fee
|
|
Common
Stock, $0.01 par value per share
|
930,177
|
$2.155
|
$2,004,531
|
$143.00
|
(1) This
represents an increase in the number of shares of common stock of the registrant
reserved for issuance under the NovaBay Pharmaceuticals, Inc. 2007 Omnibus
Incentive Plan pursuant to an evergreen provision contained therein. In
accordance with Rule 416 under the Securities Act of 1933, as amended, this
registration statement shall be deemed to cover any additional securities that
may from time to time be offered or issued resulting from stock splits, stock
dividends, recapitalization or other similar transactions.
(2)
Represents the average of the high and low prices of the Common Stock on January
20, 2010 as reported by NYSE Alternext U.S. LLC., and is set forth solely for
the purpose of calculating the filing fee pursuant to Rules 457(c) and 457(h)
under the Act.
1
EXPLANATORY
NOTE
This
Registration Statement on Form S-8 registers the offer and sale of 930,177
shares of Common Stock of NovaBay Pharmaceuticals, Inc. (the “Company”) for
issuance under the NovaBay Pharmaceuticals, Inc. 2007 Omnibus Incentive Plan, as
amended and restated (the “Plan”). The contents of the prior Registration
Statements on Form S-8 filed with the Securities and Exchange Commission (the
“Commission”) on November 13, 2007 (File No. 333-147334) and on January 30, 2009
(File No. 000-157041), relating to the Plan, are incorporated herein by
reference.
PART
II
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
|
Item
3.
|
Incorporation
of Documents by Reference.
|
The
following documents filed by the Company with Commission are incorporated by
reference into this Registration Statement:
|
|
1.
|
The
Company’s Annual Report on Form 10-K for the year ended December 31, 2008,
as filed on March 31, 2009, as amended by Form 10-K/A filed with the
Commission on August 4, 2009.
|
|
|
2.
|
The
Company’s Quarterly Report on Form 10-Q for the quarter ended September
30, 2009, as filed on November 12, 2009; the Company’s Quarterly Report of
Form 10-Q for the quarter ended June 30, 2009, as filed on August 14,
2009; and the Company’s Quarterly Report of Form 10-Q for the quarter
ended March 31, 2009, as filed on May 15, 2009, as amended by Form 10-Q/A,
as filed on August 4, 2009.
|
|
|
3.
|
The
Company’s Current Reports on Form 8-K filed on January 7, 2009, January
14, 2009, January 20, 2009 (reporting disclosures under Items 5.02 and
9.01), March 25, 2009, August 3, 2009, August 21, 2009, and December 23,
2009.
|
|
|
4.
|
The
description of the Company’s Common Stock which is contained in the
Company’s Registration Statement on Form S-1, File No. 333-140714, first
filed on February 14, 2007, as
amended.
|
All
reports and other documents subsequently filed by the Company pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a
post-effective amendment which indicates that all securities offered have been
sold or which deregisters all securities then remaining unsold, shall be deemed
to be incorporated by reference herein and to be a part of this registration
statement from the date of the filing of such reports and documents (other than
current reports furnished pursuant to Form 8-K).
|
Item
8.
|
Exhibits.
|
|
Exhibit
No.
|
Description
of Document
|
|
|
3.1(1)
|
Amended
and Restated Articles of Incorporation
|
|
|
3.2(1)
|
Amended
and Restated Bylaws
|
|
|
4.1(2)
|
Specimen
Common Stock Certificate
|
|
|
4.2
|
Reference
is made to Exhibits 3.1 and 3.2 above.
|
|
|
5.1
|
Opinion
of Cooley Godward Kronish llp
|
|
|
23.1
|
Consent
of Davidson & Company LLP
|
|
|
23.2
|
Consent
of Cooley Godward Kronish llp (included in
Exhibit 5.1)
|
|
|
24.1
|
Power
of Attorney (included in Part II of this Registration
Statement)
|
|
|
99.1(3)
|
NovaBay
Pharmaceuticals, Inc. 2007 Omnibus Incentive Plan, as
amended
|
|
|
99.2(4)
|
Forms
of agreements for use under the NovaBay Pharmaceuticals, Inc. 2007 Omnibus
Incentive Plan, as amended
|
2
|
(1)
|
Incorporated
by reference to the exhibit of the same number from the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 as
filed with the Commission on November 15,
2007.
|
|
|
(2)
|
Incorporated
by reference to the exhibit of the same number from the Company’s
Registration Statement on Form S-1 (File No. 333-140714) as filed with the
Securities and Exchange Commission on May 29, 2007, as
amended.
|
|
|
(3)
|
Incorporated
by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form
10-Q for the quarter ended June 30, 2008 (File No. 001-33628) as filed
with the Commission on August 14,
2008.
|
|
|
(4)
|
Incorporated
by reference to Exhibit 10.3 to the Company’s Registration Statement on
Form S-1 (File No. 333-140714) as filed with the Securities and Exchange
Commission on May 29, 2007, as
amended.
|
3
Pursuant
to the requirements of the Securities Act of 1933, as amended, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Emeryville, State of California on January 20,
2010.
|
NovaBay
Pharmaceuticals, Inc.
|
|
|
/s/ Ramin Najafi
|
|
|
Ramin
(“Ron”) Najafi, Ph.D.
|
|
|
Chairman
of the Board, President and Chief
|
|
|
Executive
Officer
|
POWER
OF ATTORNEY
KNOW ALL
MEN BY THESE PRESENTS that each of the undersigned officers and directors does
hereby constitute and appoint Ramin Najafi, Ph.D., Thomas J. Paulson and Theresa
Granados Uriarte, and each of them, or their substitute or substitutes, as his
or her true and lawful attorneys-in-fact and agents, with full power and
authority to do any and all acts and things and to execute and file or cause to
be filed any and all instruments, documents or exhibits which said attorneys and
agents, or either one of them, determine may be necessary or advisable or
required to enable said corporation to comply with the Securities Act of 1933,
as amended, and any rules or regulations or requirements of the Securities and
Exchange Commission in connection with this registration
statement. Without limiting the generality of the foregoing power and
authority, the powers granted include the power and authority to sign the names
of the undersigned officers and directors in the capacities indicated below to
this registration statement, to any and all amendments, both pre-effective and
post-effective, and supplements to this registration statement and to any and
all instruments, documents or exhibits filed as part of or in conjunction with
this registration statement or amendments or supplements thereof, with the
powers of substitution and revocation, and each of the undersigned hereby
ratifies and confirms all that said attorneys and agents, or either one of them,
or their substitute or substitutes, shall lawfully do or cause to be done by
virtue hereof. In witness whereof, each of the undersigned has
executed this Power of Attorney as of the dates indicated below.
Pursuant
to the requirements of the Securities Act of 1933, this registration statement
has been signed by the following persons in the capacities and on the dates
indicated:
|
Signature
|
Title
|
Date
|
||
|
/s/
Ramin Najafi
|
Chairman
of the Board, Chief Executive Officer and President (principal executive
officer)
|
January
18, 2010
|
||
|
Ramin
(“Ron”) Najafi, Ph.D.
|
||||
|
/s/
Thomas J. Paulson
|
Chief
Financial Officer and Treasurer
(principal
financial and accounting officer)
|
January
18, 2010
|
||
|
Thomas
J. Paulson
|
||||
|
/s/
Charles J. Cashion
|
Director
|
January
20, 2010
|
||
|
Charles
J. Cashion
|
||||
|
/s/
Anthony Dailley
|
Director
|
January
13, 2010
|
||
|
Anthony
Dailley, D.D.S.
|
||||
|
/s/
Paul E. Freiman
|
Director
|
January
20, 2010
|
||
|
Paul
E. Freiman
|
||||
|
/s/
Harry F. Hixson, Jr.
|
Director
|
January
20, 2010
|
||
|
Harry
F. Hixson, Jr., Ph.D.
|
||||
|
/s/
T. Alex McPherson
|
Director
|
January
13, 2010
|
||
|
T.
Alex McPherson, M.D., Ph.D.
|
||||
|
/s/
Robert R. Tufts
|
Director
|
January
13, 2010
|
||
|
Robert
R. Tufts
|
||||
|
/s/
Tony D.S. Wicks
|
Director
|
January
13, 2010
|
||
|
Tony
D.S. Wicks
|
4
EXHIBIT
INDEX
|
Exhibit
No.
|
Description
of Document
|
|
|
3.1(1)
|
Amended
and Restated Articles of Incorporation
|
|
|
3.2(1)
|
Amended
and Restated Bylaws
|
|
|
4.1(2)
|
Specimen
Common Stock Certificate
|
|
|
4.1
|
Reference
is made to Exhibits 3.1 and 3.2 above.
|
|
|
Opinion
of Cooley Godward Kronish llp
|
||
|
Consent
of Davidson & Company LLP
|
||
|
23.2
|
Consent
of Cooley Godward Kronish llp (included in
Exhibit 5.1)
|
|
|
24.1
|
Power
of Attorney (included in Part II of this Registration
Statement)
|
|
|
99.1(3)
|
NovaBay
Pharmaceuticals, Inc. 2007 Omnibus Incentive Plan, as
amended
|
|
|
99.2(4)
|
Forms
of agreements for use under the NovaBay Pharmaceuticals, Inc. 2007 Omnibus
Incentive Plan, as amended
|
|
|
(1)
|
Incorporated
by reference to the exhibit of the same number from the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 as
filed with the Commission on November 15,
2007.
|
|
|
(2)
|
Incorporated
by reference to the exhibit of the same number from the Company’s
Registration Statement on Form S-1 (File No. 333-140714) as filed with the
Securities and Exchange Commission on May 29, 2007, as
amended.
|
|
|
(3)
|
Incorporated
by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form
10-Q for the quarter ended June 30, 2008 (File No. 001-33628) as filed
with the Commission on August 14,
2008.
|
|
|
(4)
|
Incorporated
by reference to Exhibit 10.3 to the Company’s Registration Statement on
Form S-1 (File No. 333-140714) as filed with the Securities and Exchange
Commission on May 29, 2007, as
amended.
|
5